US Patent Issued to OneCell Diagnostics on Feb. 10 for "Multiplexed assay for quantitating and assessing integrity of cell-free DNA in biological fluids for cancer diagnosis, prognosis and surveillance" (Louisiana Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,954, issued on Feb. 10, was assigned to OneCell Diagnostics Inc. (Cupertino, Calif.).

"Multiplexed assay for quantitating and assessing integrity of cell-free DNA in biological fluids for cancer diagnosis, prognosis and surveillance" was invented by Sudhir Sinha (Metairie, La.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A retrotransposable element based multiplexed qPCR assay to robustly quantitate and distinguish cell free DNA integrity and concentration in blood plasma and serum is described. The multiplexed system for characterizing cancer in humans includes a sample of serum, plasma, urine, or other biological fluid, the sample comprising cel...